Clinical trial Recruiting at 1 site Interventional Ages 18 to 60

Combining Cognitive Behavioral Therapy with Brain Stimulation for OCD Treatment

Official title: A Randomized, Double-Blind, Clinical Trial to Study the Efficacy and Mechanisms of Transcranial Alternating Current Stimulation (tACS) Concurrent With Exposure-based Cognitive-Behavioral Therapy (CBT) for Obsessive-Compulsive Disorder (OCD)

Run by Shanghai Mental Health Center · NCT06717165 · Data updated 2026-11-12

This study is testing if combining a type of therapy called Cognitive Behavioral Therapy with a brain stimulation technique can help people with obsessive-compulsive disorder feel better.

Quick facts

Study typeInterventional
Ages18 Years to 60 Years
SexAll
Enrollment62 (estimated)
SponsorShanghai Mental Health Center
Academic / other
Locations1 site (Shanghai, Shanghai Municipality)
StatusRecruiting
StartedApril 15, 2024
Main results expectedOctober 30, 2027
Study endsDecember 31, 2027
Registry record updatedAugust 1, 2025
Trial IDNCT06717165 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18-60 with a confirmed diagnosis of OCD and a Y-BOCS score of 16 or higher.

Probably not a fit

Patients with severe OCD symptoms that hinder assessment, those with serious medical or neurological conditions, or those currently on antiepileptic medication may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of combining exposure-based Cognitive Behavioral Therapy (CBT) with Transcranial Alternating Current Stimulation (tACS) in treating patients with obsessive-compulsive disorder (OCD). A total of 120 participants will be randomized into three groups: one receiving active tACS with CBT, another receiving sham tACS with CBT, and a waiting list group. The treatment will consist of 10 sessions over two months, with assessments of OCD symptoms and EEG monitoring to explore the neural mechanisms involved. The goal is to determine if the combination of tACS and CBT enhances treatment outcomes for OCD patients.

Why it matters

Potential benefit: If successful, this approach could significantly improve treatment outcomes for patients with OCD.

How similar studies have gone: While the combination of CBT and tACS is a novel approach, previous studies have shown promise in using tACS for various neurological and psychiatric conditions.

Who can join: the full rules

Show full inclusion / exclusion criteria
The investigators recruited outpatient adults with OCD confirmed by the Mini-International Neuropsychiatric Interview (MINI). The following inclusion and exclusion criteria were also applied:

Inclusion Criteria:

* 18-60 years old
* With at least 9 years of education
* Y-BOCS score ≥16
* No history of serious medical, neurological illness or other psychotic disorders other than OCD (anxiety or mild to moderate depression secondary to OCD was not exclusionary)
* Medication-free or had received stable medication for at least 8 weeks before entering the study and continued the same medication throughout the study

Exclusion Criteria:

* History of serious medical, neurological illness or other psychotic disorders other than OCD
* OCD symptoms are severe, preventing the patient from completing the required assessment and examination
* Serious suicide risk
* Women who are pregnant or planning to become pregnant
* Currently taking antiepileptic medication
* Clinically significant physical illnesses or laboratory test abnormalities that have clinical significance
* Previous completion of a full course of CBT/ERP treatment

Where it's running

  • Shanghai Mental Health Center
    Shanghai, Shanghai Municipality, China
    Recruiting

Study contacts

  • Principal investigator: Zhen Wang, PhD, MD — Shanghai Mental Health Center
  • Study coordinator: Zhen Wang, PhD, MD
  • Email: wangzhen@smhc.org.cn
  • Phone: +86 34773516

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.